Synchrogenix Competitors and Similar CompaniesClear all

Synchrogenix's competitors and similar companies include Axis Clinicals, Chemveda Life Sciences, SNBL and Medical Research Network.

	Synchrogenix Synchrogenix Information Strategies is a provider of regulatory solutions for pharmaceutical, device diagnostics, and tobacco companies.	Axis Clinicals Axis Clinicals is a provider of contract research services.	Chemveda Life Sciences Chemveda Life Sciences is a contract research organization.	SNBL SNBL (Shin Nippon Biomedical Laboratories, 株式会社新日本科学) is a contract research company specializing in preclinical and clinical studies.	Medical Research Network Medical Research Network (also known as MRN and MRN inflection) is a clinical trial support organization focused on clinical trial delivery.
Founding Date	Founding Date 1986	Founding Date 2004	Founding Date 2008	Founding Date 1957	Founding Date 2006
Type	Type Subsidiary	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare clinical research	Tags Healthcare clinical research	Tags Healthcare clinical research	Tags Healthcare clinical research	Tags Healthcare clinical research
Locations	Locations Wilmington, US HQ Montréal, CA Makati, PH Daresbury, GB London, GB Atlanta, US Cincinnati, US see more	Locations Serilingampalle (M), IN HQ St. Cloud, US	Locations San Diego, US HQ Hyderabad, IN	Locations Tokyo, JP HQ Kagoshima, JP Kainan, JP Osaka, JP Everett, US San Luis, US	Locations Crownhill, GB HQ Stuttgart, DE Shinjuku City, JP Madrid, ES Deerfield, US
Employees	Employees 203	Employees 587	Employees 3402% increase	Employees 1,436	Employees 3061% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥32.4b (FY, 2025)	Revenue (est.) £38m (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥13.2b (FY, 2025)	Cost of goods £14.6m (FY, 2020)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥19.2b (FY, 2025)	Gross profit £23.4m (FY, 2020)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ¥4.9b (FY, 2025)	Net income £5.3m (FY, 2020)